Analisis ketahanan hidup 5 tahun penderita kaker ovarium epithelial dengan kadar serum albumin sebagai faktor prognostik di RS Kanker Dharmais Jakarta tahun 1996-2004 = 5 Years survival analysis on epithelial ovarian cancer patients and albumin as prognostic factor at the Dhannais Cancer Hospital Jakarta l996-2004
| Main Authors: | Dieta Nurrika, author, Add author: Bambang Dwipoyono, examiner |
|---|---|
| Format: | Masters Bachelors |
| Terbitan: |
, 2010
|
| Online Access: |
https://lib.ui.ac.id/detail?id=20341200 |
Daftar Isi:
- <b>ABSTRAK</b><br> Ovarian cancer is one of the largest cause of death in women. lt is often refered to as the silent killer because the symtoms remain unseen to the patient. The number of ovarian cancer cases varies in each country. For example, the rate of ovarian cancer in countries such as Asia and Aliica lower rather than in most industrialized countries like Europe and North America. Rate of Epithelial ovarian cancer in women ages 45-49 was l6.4 cases per i00,000 people. The risk of being diagnosed increases with age. The risk more than doubles in women 60 and over with 40 cases per l00,000, and the highest rate at 61 cases to 100,000 is in the age group of women 80-84. Cun-ently, infomation regarding ovarian cancer in Indonesia is limited, but Dharmais Cancer Hospital found about 30 new cases of ovarian cancer every year. The purpose of this study is to determine the probability of serum albumin levels in the survivors of epithelial ovarian cancer at Dharmais Cancer Hospital in Jakarta in 1996-2004. Design study is retrospective cohort using secondary data epithelial ovarian cancer patients at Dharmais Cancer Hospital. The study uses observations of 48 patients from the time of their diagnotior: until they are cured, their death or they lost to follow up. The data were analyzed using survival analysis. The results shows that overall probability five-year survival in patients with epithelial ovarian cancer at the Dharmais Cancer Hospital Jakarta in 19964004 is 26.2% the probability of patients surviving five years on the scmm albumin with 2 3.6 mg / dl was 36.1% whiehis higher than those of patients with scmm albumin 6.6 mg/ di at l5.7%. After controled by stage of the cancer, the ascites and hemoglobin levels of the patients with an albumin level of < 3.6 mg I dl had a risk of death 7.979 times higher than with an a";urnin level 2 3.6 mg/ dl.